| Your Current Location : Fund Card : Fund Summary |
 |
|
|
| |
| WhiteOak Capital Pharma and Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
|
| |
| Fund Details |
| Fund Type |
Growth |
Launch Date |
16 Jan 2024 |
| Corpus(Cr.) |
254.0 |
Scheme NAV |
13.566 |
| Equity(%) |
74.22 |
52 Week High |
13.685 |
| Debt(%) |
25.78 |
52 Week Low |
9.529 |
| Others(%) |
0.0 |
Exit Load |
1% for redemption within 1 month |
| Minimum Investment |
- |
Availability |
Open |
| Entry Load |
- |
Expense Ratio(%) |
0.68 |
| Scheme Benchmark |
BSE Healthcare TRI |
Broader Benchmark |
NSE - Nifty 50 TRI |
|
| |
| Scheme Objective |
| The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. |
| |
|
|
| |
|
|
| |
|
 |
| |
|
|
|
